Pharmaceutical Business review

Novasep gets FDA nod for two synthesis sites in 2011

Chasse-sur-Rhone provides for process scale-ups, the supply of clinical batches and the regular production of low volume compounds under cGMP.

Freeport site performs custom manufacturing services from late stage clinical trials through to multi-ton commercial production for API’s

Novasep Synthesis president Patrick Glaser said their scope of synthesis and purification technologies and know-how enables them to produce the increasingly complex molecules with purity.

Novasep Synthesis is the synthetic molecule contract manufacturing division of Novasep.